Global Molecular Diagnostics in Cancer Testing Market Research Report 2017

January 2017 | 123 pages | ID: G566A05AE1FEN
QYResearch

Abstracts

Notes:

Production, means the output of Molecular Diagnostics in Cancer Testing

Revenue, means the sales value of Molecular Diagnostics in Cancer Testing

This report studies Molecular Diagnostics in Cancer Testing in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Abbott Molecular Diagnostics
• Accugenomics
• Agendia
• Ambry Genetics
• Biodesix
• bioMerieux
• bioTheranostics (AviaraDx)
• Cancer Genetics
• Clarient, Inc. (GE Healthcare)
• Counsyl
• Flatiron Health
• Epigenomics
• Exact Sciences Corporation
• Exiqon
• Genomic Health
• Genoptix (Novartis)
• Genmark Diagnostics
• Genomictree
• HTG Molecular Diagnostics
• Invitae
• LabCorp
• Myriad Genetics
• Nanostring
• Neogenomics
• NSTG
• Nuvera Biosciences
• Orion Genomics
• Pathway Genomics

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Molecular Diagnostics in Cancer Testing in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by application, this report focuses on consumption, market share and growth rate of Molecular Diagnostics in Cancer Testing in each application, can be divided into

• Application 1
• Application 2

Contents

Global Molecular Diagnostics in Cancer Testing Market Research Report 2017

1 MOLECULAR DIAGNOSTICS IN CANCER TESTING MARKET OVERVIEW

1.1 Product Overview and Scope of Molecular Diagnostics in Cancer Testing
1.2 Molecular Diagnostics in Cancer Testing Segment by Type
  1.2.1 Global Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
1.3 Molecular Diagnostics in Cancer Testing Segment by Application
  1.3.1 Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
1.4 Molecular Diagnostics in Cancer Testing Market by Region
  1.4.1 North America Status and Prospect (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 China Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Molecular Diagnostics in Cancer Testing (2012-2022)

2 GLOBAL MOLECULAR DIAGNOSTICS IN CANCER TESTING MARKET COMPETITION BY MANUFACTURERS

2.1 Global Molecular Diagnostics in Cancer Testing Production and Share by Manufacturers (2015 and 2016)
2.2 Global Molecular Diagnostics in Cancer Testing Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Molecular Diagnostics in Cancer Testing Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Molecular Diagnostics in Cancer Testing Manufacturing Base Distribution, Sales Area and Product Type
2.5 Molecular Diagnostics in Cancer Testing Market Competitive Situation and Trends
  2.5.1 Molecular Diagnostics in Cancer Testing Market Concentration Rate
  2.5.2 Molecular Diagnostics in Cancer Testing Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL MOLECULAR DIAGNOSTICS IN CANCER TESTING PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Molecular Diagnostics in Cancer Testing Production and Market Share by Region (2012-2017)
3.2 Global Molecular Diagnostics in Cancer Testing Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL MOLECULAR DIAGNOSTICS IN CANCER TESTING SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

4.1 Global Molecular Diagnostics in Cancer Testing Consumption by Regions (2012-2017)
4.2 North America Molecular Diagnostics in Cancer Testing Production, Consumption, Export, Import (2012-2017)
4.3 Europe Molecular Diagnostics in Cancer Testing Production, Consumption, Export, Import (2012-2017)
4.4 China Molecular Diagnostics in Cancer Testing Production, Consumption, Export, Import (2012-2017)
4.5 Japan Molecular Diagnostics in Cancer Testing Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Molecular Diagnostics in Cancer Testing Production, Consumption, Export, Import (2012-2017)
4.7 India Molecular Diagnostics in Cancer Testing Production, Consumption, Export, Import (2012-2017)

5 GLOBAL MOLECULAR DIAGNOSTICS IN CANCER TESTING PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Molecular Diagnostics in Cancer Testing Production and Market Share by Type (2012-2017)
5.2 Global Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)
5.3 Global Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)
5.4 Global Molecular Diagnostics in Cancer Testing Production Growth by Type (2012-2017)

6 GLOBAL MOLECULAR DIAGNOSTICS IN CANCER TESTING MARKET ANALYSIS BY APPLICATION

6.1 Global Molecular Diagnostics in Cancer Testing Consumption and Market Share by Application (2012-2017)
6.2 Global Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL MOLECULAR DIAGNOSTICS IN CANCER TESTING MANUFACTURERS PROFILES/ANALYSIS

7.1 Abbott Molecular Diagnostics
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Accugenomics
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Agendia
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Agendia Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Ambry Genetics
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Biodesix
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Biodesix Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 bioMerieux
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 bioTheranostics (AviaraDx)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Cancer Genetics
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Clarient, Inc. (GE Healthcare)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Counsyl
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Counsyl Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Flatiron Health
7.12 Epigenomics
7.13 Exact Sciences Corporation
7.14 Exiqon
7.15 Genomic Health
7.16 Genoptix (Novartis)
7.17 Genmark Diagnostics
7.18 Genomictree
7.19 HTG Molecular Diagnostics
7.20 Invitae
7.21 LabCorp
7.22 Myriad Genetics
7.23 Nanostring
7.24 Neogenomics
7.25 NSTG
7.26 Nuvera Biosciences
7.27 Orion Genomics
7.28 Pathway Genomics

8 MOLECULAR DIAGNOSTICS IN CANCER TESTING MANUFACTURING COST ANALYSIS

8.1 Molecular Diagnostics in Cancer Testing Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Molecular Diagnostics in Cancer Testing Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MOLECULAR DIAGNOSTICS IN CANCER TESTING MARKET FORECAST (2017-2022)

12.1 Global Molecular Diagnostics in Cancer Testing Production, Revenue and Price Forecast (2017-2022)
  12.1.1 Global Molecular Diagnostics in Cancer Testing Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Molecular Diagnostics in Cancer Testing Price and Trend Forecast (2017-2022)
12.2 Global Molecular Diagnostics in Cancer Testing Production, Consumption, Import and Export Forecast by Regions (2017-2022)
  12.2.1 North America Molecular Diagnostics in Cancer Testing Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Molecular Diagnostics in Cancer Testing Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Molecular Diagnostics in Cancer Testing Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Molecular Diagnostics in Cancer Testing Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Molecular Diagnostics in Cancer Testing Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Molecular Diagnostics in Cancer Testing Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Molecular Diagnostics in Cancer Testing Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Molecular Diagnostics in Cancer Testing Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Molecular Diagnostics in Cancer Testing
Figure Global Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure North America Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Molecular Diagnostics in Cancer Testing Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Molecular Diagnostics in Cancer Testing Production of Key Manufacturers (2015 and 2016)
Table Global Molecular Diagnostics in Cancer Testing Production Share by Manufacturers (2015 and 2016)
Figure 2015 Molecular Diagnostics in Cancer Testing Production Share by Manufacturers
Figure 2016 Molecular Diagnostics in Cancer Testing Production Share by Manufacturers
Table Global Molecular Diagnostics in Cancer Testing Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers
Table 2016 Global Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers
Table Global Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers in 2015
Table Manufacturers Molecular Diagnostics in Cancer Testing Manufacturing Base Distribution and Sales Area
Table Manufacturers Molecular Diagnostics in Cancer Testing Product Type
Figure Molecular Diagnostics in Cancer Testing Market Share of Top 3 Manufacturers
Figure Molecular Diagnostics in Cancer Testing Market Share of Top 5 Manufacturers
Table Global Molecular Diagnostics in Cancer Testing Production by Regions (2012-2017)
Figure Global Molecular Diagnostics in Cancer Testing Production and Market Share by Regions (2012-2017)
Figure Global Molecular Diagnostics in Cancer Testing Production Market Share by Regions (2012-2017)
Figure 2015 Global Molecular Diagnostics in Cancer Testing Production Market Share by Regions
Table Global Molecular Diagnostics in Cancer Testing Revenue by Regions (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Revenue Market Share by Regions (2012-2017)
Table 2015 Global Molecular Diagnostics in Cancer Testing Revenue Market Share by Regions
Table Global Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
Table India Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Consumption Market by Regions (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Consumption Market Share by Regions (2012-2017)
Figure Global Molecular Diagnostics in Cancer Testing Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Molecular Diagnostics in Cancer Testing Consumption Market Share by Regions
Table North America Molecular Diagnostics in Cancer Testing Production, Consumption, Import & Export (2012-2017)
Table Europe Molecular Diagnostics in Cancer Testing Production, Consumption, Import & Export (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Import & Export (2012-2017)
Table Japan Molecular Diagnostics in Cancer Testing Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Molecular Diagnostics in Cancer Testing Production, Consumption, Import & Export (2012-2017)
Table India Molecular Diagnostics in Cancer Testing Production, Consumption, Import & Export (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Production by Type (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Production Share by Type (2012-2017)
Figure Production Market Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)
Figure 2015 Production Market Share of Molecular Diagnostics in Cancer Testing by Type
Table Global Molecular Diagnostics in Cancer Testing Revenue by Type (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)
Figure 2015 Revenue Market Share of Molecular Diagnostics in Cancer Testing by Type
Table Global Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)
Figure Global Molecular Diagnostics in Cancer Testing Production Growth by Type (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Consumption by Application (2012-2017)
Table Global Molecular Diagnostics in Cancer Testing Consumption Market Share by Application (2012-2017)
Figure Global Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015
Table Global Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)
Figure Global Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)
Table Abbott Molecular Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Accugenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Accugenomics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Accugenomics Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Agendia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agendia Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Agendia Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Ambry Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ambry Genetics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Ambry Genetics Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Biodesix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biodesix Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Biodesix Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table bioMerieux Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table bioMerieux Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure bioMerieux Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table bioTheranostics (AviaraDx) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Cancer Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cancer Genetics Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Cancer Genetics Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Clarient, Inc. (GE Healthcare) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Counsyl Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Counsyl Molecular Diagnostics in Cancer Testing Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Counsyl Molecular Diagnostics in Cancer Testing Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Molecular Diagnostics in Cancer Testing
Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
Figure Molecular Diagnostics in Cancer Testing Industrial Chain Analysis
Table Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015
Table Major Buyers of Molecular Diagnostics in Cancer Testing
Table Distributors/Traders List
Figure Global Molecular Diagnostics in Cancer Testing Production and Growth Rate Forecast (2017-2022)
Figure Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)
Figure Global Molecular Diagnostics in Cancer Testing Price and Trend Forecast (2017-2022)
Table Global Molecular Diagnostics in Cancer Testing Production Forecast by Regions (2017-2022)
Table Global Molecular Diagnostics in Cancer Testing Consumption Forecast by Regions (2017-2022)
Figure North America Molecular Diagnostics in Cancer Testing Production, Revenue and Growth Rate Forecast (2017-2022)
Table North America Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import Forecast (2017-2022)
Figure Europe Molecular Diagnostics in Cancer Testing Production, Revenue and Growth Rate Forecast (2017-2022)
Table Europe Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import Forecast (2017-2022)
Figure China Molecular Diagnostics in Cancer Testing Production, Revenue and Growth Rate Forecast (2017-2022)
Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import Forecast (2017-2022)
Figure Japan Molecular Diagnostics in Cancer Testing Production, Revenue and Growth Rate Forecast (2017-2022)
Table Japan Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import Forecast (2017-2022)
Figure Southeast Asia Molecular Diagnostics in Cancer Testing Production, Revenue and Growth Rate Forecast (2017-2022)
Table Southeast Asia Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import Forecast (2017-2022)
Figure India Molecular Diagnostics in Cancer Testing Production, Revenue and Growth Rate Forecast (2017-2022)
Table India Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import Forecast (2017-2022)
Table Global Molecular Diagnostics in Cancer Testing Production Forecast by Type (2017-2022)
Table Global Molecular Diagnostics in Cancer Testing Revenue Forecast by Type (2017-2022)
Table Global Molecular Diagnostics in Cancer Testing Price Forecast by Type (2017-2022)
Table Global Molecular Diagnostics in Cancer Testing Consumption Forecast by Application (2017-2022)